Market closed · Next open: Monday 9:30 AM ET
Last update: Oct 30, 2026, 6:17 PM ET

Stock Analysis

WIX Stock: Wix's Base44 AI Pivot, Layoffs, Buyback and Guidance Cut Explained

Wix repurchased 30% of its shares at $92 in April. By June 8, WIX closed at $48.21 after a Q1 loss, 20% layoffs and a guidance cut driven by Base44's AI costs.

By Roberto LiccardoPublished (ET)8 min readWIX
Illustration of the Wix website editor open on a desktop monitor, with a drag-and-drop page build for a small online store

Summary: Why WIX Stock Sold Off

Wix (NASDAQ: WIX) has packed a lot of bad news into eight weeks. The company missed first-quarter estimates on May 13 and swung to a GAAP net loss of $57.5 million [1]. On May 28 it announced the largest layoff in its history, about 1,000 jobs or 20% of the workforce [2]. On June 8 it cut its full-year outlook [3], and the stock closed at $48.21. All of this came after Wix spent $1.6 billion in April to repurchase roughly 30% of its own shares at $92 apiece [1]. The common thread is the cost of the company's answer to AI competition: the Base44 acquisition is growing fast, but compute and marketing expenses have pushed Wix into the red while its core Partners business slows.

WIX: key numbersFigure
Q1 2026 revenue$541.2M (+14% y/y)
Q1 2026 bookings$585.0M (+15% y/y)
GAAP net loss (Q1 2026)$57.5M
Non-GAAP diluted EPS$0.68 (vs. $1.22 consensus)
Free cash flow (Q1 2026)$75.0M
Tender offer price$92.00
Shares repurchased17.5M (~30% of shares out)
Workforce reduction~1,000 jobs / 20%
Annualized savings target~$150M
Base44 ARR~$150M as of mid-May 2026
June 8, 2026 close$48.21

Q1 figures per Wix's earnings release and call [1][4]; consensus per cited reporting [5]; June 8 closing price via FMP.

DateKey events behind Wix's 2026 reset
Jun 18, 2025Wix acquires vibe-coding startup Base44 for ~$80M initial consideration plus earnouts through 2029 [6]
Apr 2026$1.6B tender offer completed: 17.5M shares repurchased at $92, ~30% of shares outstanding [1]
May 13, 2026Q1 miss: GAAP loss of $57.5M, non-GAAP operating margin 5% (from 21%). Stock falls 27% [1][7]
May 28, 2026Largest layoff in company history: ~1,000 roles, 20% of the workforce [2]
Jun 8, 20262026 guidance cut: bookings to low-teens growth, revenue to low- to mid-teens. WIX closes at $48.21 [3]

What Changed: Q1 Results, Base44 Costs, the Buyback and Layoffs

Start with the quarter. Revenue rose 14% to $541.2 million and bookings grew 15% to $585 million, in line with what Wix has delivered for years [1][8]. Profitability is another story. Non-GAAP net income fell from $93.9 million a year earlier to $42.5 million, non-GAAP operating margin dropped from 21% to 5%, and free cash flow fell from $142.4 million to $75 million [1]. Adjusted EPS of $0.68 missed the $1.22 consensus by 44% [5]. The stock fell 27% on the report [7].

Bar chart comparing Wix Q1 2025 and Q1 2026: GAAP net income fell from $33.8M to a $57.5M loss, non-GAAP net income from $93.9M to $42.5M, free cash flow from $142.4M to $75M
Growth held up. Profit did not. Q1 2025 vs. Q1 2026, from Wix's earnings release (May 13, 2026).

Base44: the AI bet raising revenue and costs

Two costs did most of the damage. The first is Base44, the vibe-coding startup Wix bought in June 2025 for roughly $80 million in initial consideration plus earnouts through 2029 [6]. The product works: ARR went from $100 million in early March to $150 million by mid-May [4]. But every new Base44 user arrives with an AI inference bill, and management attributed part of the drop in gross margin to 66% to that compute [4]. The second is marketing, including Super Bowl campaigns to push Base44 and widen the funnel [4][5].

Base44 ARR: +50% in about ten weeks $100M $150M Early March 2026 Mid-May 2026 Source: Wix Q1 2026 earnings call (May 13, 2026). Base44 acquired June 2025 for ~$80M initial consideration.
Base44 ARR, early March to mid-May 2026. The compute bill grew with it. Source: Wix Q1 2026 earnings call.

The $1.6B buyback looks worse after the selloff

Then the capital structure. In April, Wix completed a $1.6 billion modified Dutch auction tender, retiring 17.5 million shares at $92 each and leaving about 41.8 million shares outstanding [1]. WIX closed at $48.21 on June 8, 2026, about 47.6% below the $92 tender offer price.

Tender price vs. June 8 close $92.00 $48.21 −47.6% Tender offer price (April 2026) Closing price (June 8, 2026) Sources: Wix Q1 2026 earnings release ($1.6B tender, 17.5M shares at $92); June 8, 2026 close via FMP.
The April 2026 tender price against the June 8, 2026 close, a 47.6% gap. Prices as of the dates shown; closing price via FMP.

Layoffs and a guidance cut inside two weeks

Management responded on May 28 with a plan to cut about 1,000 roles, around 20% of a 5,277-person workforce, and to flatten the org chart [2]. CEO Avishai Abrahami also pointed at the shekel, which has strengthened against the dollar and adds roughly $64 million of expense headwind this year [1][2]. On June 8, a 6-K filing trimmed guidance: bookings growth is now expected in the low teens (from mid-teens) and revenue growth in the low- to mid-teens, about $50 million less in bookings and $25 million less in revenue than planned a month earlier [3]. The layoffs should save about $70 million in 2026 and roughly $150 million annualized, against a one-time charge of $30–35 million [3][9].

Why It Matters for WIX Stock

Wix is turning into the test case for what happens when an incumbent buys its own disruptor. Base44 settles the strategic question: Wix now owns a credible AI-native builder instead of watching rivals such as Lovable take its future customers [7]. It does not settle the economics. Creative Subscriptions, the traditional core, runs at an 80% non-GAAP gross margin [4]; AI app generation carries inference costs that model never had to absorb. Growth at Base44 raises revenue and costs at the same time, which is how a company can grow 14% and still lose money.

The buyback compounds the stakes. Wix moved to a net debt position, took on a $500 million credit facility, and gave up interest income on the cash it spent [1]. With about 41.8 million shares outstanding, every swing in the business now hits per-share numbers harder, in both directions. And the more conventional problem may be the bigger one: the Partners business, about 38% of revenue, slowed sharply in late May and early June, and the company acknowledged the weakness goes beyond its own restructuring [9].

What Investors Should Watch Next

Wix is expected to report second-quarter earnings in early August [10]. Base44's gross margin trajectory matters most; management projected quarter-over-quarter improvement and a significant change by year-end as AI costs get optimized and user cohorts shift into a cheaper maintenance phase [4]. Watch whether Partners growth stabilizes after the May–June slump, whether the $70 million of 2026 savings shows up net of the $30–35 million severance charge, and whether free cash flow tracks toward the roughly $420 million full-year target [3][9].

Two variables sit outside management's control: the shekel-dollar exchange rate, which moves the cost base directly, and the pace at which competitors keep cutting the price of AI site-building. Wix Harmony, the company's proprietary model, is its main lever on compute costs; on the Q1 call, management said it already lowered model costs while output quality improved [4]. Whether that holds at Base44's scale will decide if low-teens growth can coexist with recovering margins.

Is WIX stock below its buyback price?

Yes. Wix repurchased 17.5 million shares at $92.00 in its April 2026 tender offer [1], and WIX closed at $48.21 on June 8, 2026 — 47.6% below the tender price. The gap is measured from the $92 tender price to the June 8 closing price, not to an intraday level.

Why did WIX stock fall in 2026?

  • A Q1 earnings miss (May 13). Non-GAAP EPS of $0.68 vs. a $1.22 consensus, a swing to a $57.5 million GAAP net loss, and operating margin down from 21% to 5%. The stock fell 27% on the report [1][5][7].
  • Base44 compute and marketing costs. Gross margin fell to 66% as AI inference and Super Bowl-scale campaigns scaled with Base44's growth [4].
  • The largest layoff in company history (May 28). About 1,000 roles, 20% of the workforce, citing AI disruption and shekel strength [2].
  • A guidance cut (June 8). Bookings growth lowered to the low teens and revenue to the low- to mid-teens, with a sharper-than-expected Partners slowdown [3][9].

Wix guidance: May 13 vs. June 8, 2026

The June revision is the cleanest measure of how fast the picture changed: both lines below are the company's own targets, four weeks apart.

Metric (FY 2026)May 13 guidanceJune 8 guidanceChange
Bookings growthMid-teens %Low-teens %~$50M lower bookings
Revenue growthMid-teens %Low- to mid-teens %~$25M lower revenue
Free cash flow (ex. acquisition/restructuring costs)~$400M implied~$420M+~$20M
Cost savings from realignment—~$70M in 2026; ~$150M annualizedNew
One-time restructuring charge—$30–35M pre-taxNew

Baselines are Wix's May 13, 2026 earnings release and its June 8, 2026 6-K [1][3]. The ~$400M prior FCF figure is implied by the reported ~$20M raise to ~$420M [9] and is approximate.

What could move WIX next?

  • Q2 2026 earnings (expected early August). First quarter with layoff savings partially in the run rate; Base44 gross margin is the number to check [10][4].
  • Partners business data. The segment (~38% of revenue) drove the June guidance cut; stabilization or further erosion moves the growth story either way [9].
  • Restructuring execution. Roughly $70M of 2026 savings against a $30–35M charge; free cash flow tracking toward ~$420M ex-costs [3].
  • Shekel-dollar exchange rate. A ~$64M expense headwind this year; further shekel strength deepens it [1].
  • Ongoing filings and estimate revisions. New 6-K filings, guidance updates and analyst-estimate changes will show whether June's cut was a floor or a step down — the kind of signal BestStocks surfaces with the change-detection process behind the site.

WIX stock FAQ

What is Wix's ticker symbol?

Wix.com Ltd. trades on the Nasdaq under the ticker WIX.

Why did WIX stock fall in 2026?

Three hits in eight weeks: a May 13 Q1 report that missed EPS estimates ($0.68 vs. $1.22) and showed a $57.5 million GAAP net loss, a 20% workforce cut announced May 28, and a June 8 guidance reduction. WIX closed at $48.21 on June 8, 2026, about 48% below the April buyback price.

What is Base44 and why does it matter for Wix?

Base44 is a vibe-coding platform that builds apps from natural-language prompts. Wix acquired it in June 2025 for about $80 million in initial consideration plus earnouts through 2029. Its ARR reached roughly $150 million by mid-May 2026, but the AI compute behind that growth weighs on Wix's gross margin.

What is Wix's 2026 guidance now?

As of the June 8, 2026 update: bookings growth in the low teens, revenue growth in the low- to mid-teens, and free cash flow of roughly $420 million excluding acquisition and restructuring costs.

How big was the Wix buyback?

A $1.6 billion modified Dutch auction tender completed in April 2026. Wix repurchased 17.5 million shares at $92 each, about 30% of shares outstanding, leaving roughly 41.8 million shares.

When are Wix's next earnings?

Wix is expected to report Q2 2026 results in early August 2026.

View all research →
An abstract visualization of a falling stock chart over a search and AI motif in orange-red tones, representing Reddit's crash after a Q3 revenue beat was overshadowed by a Google AI search-traffic warning.
Stock AnalysisOctober 30, 2026 · 12 min read

Reddit (RDDT) Crashes ~30% After a Q3 Beat on a Google AI Search-Traffic Warning

Reddit crashed about 30% to roughly $90.79 on October 30 — a striking reaction, because the quarter itself was strong: revenue of $895 million rose 53% year over year, a clear beat, with net income of $283 million, diluted EPS of $1.40 and adjusted EBITDA of $402 million. The stock cratered on what management said about the future. On the earnings call, CEO Steve Huffman warned that search referrals fell more than a million per week on average in October as Google answers more queries with AI, and that daily active users (around 130 million) could fall a low-double-digit percentage in the fourth quarter if the trend held. Investors also fixed on a 2% year-over-year decline in US daily actives — Reddit's most valuable market, where revenue per user is more than five times the international level — and on fourth-quarter revenue guidance of $1.00–$1.03 billion that came in below expectations; Citizens downgraded the stock before the open. The one bullish counterweight was monetization: revenue per user still jumped 36% globally. The move was company-specific — Reddit's roughly 30% drop was about four times the moves of social peers Snap and Pinterest (each down ~7%), on a day the broad market fell about 2%. After the crash Reddit trades at roughly 14 times forward earnings with about $3 billion of net cash — not expensive for 50%-plus growth, if the growth is durable. The whole debate is whether rising revenue per user can keep outrunning a top of the funnel that AI search is draining.

An abstract visualization of a falling stock chart over an automotive and circuit-grille motif in steel-blue and red tones, representing General Motors' drop after a Q3 beat-and-raise was overshadowed by 2027 cost and EV concerns.
Stock AnalysisOctober 20, 2026 · 10 min read

General Motors (GM) Falls ~8% Despite a Q3 Beat and a $20B Buyback

General Motors fell about 8% to roughly $75.77 on October 20 — a striking reaction, because GM beat on third-quarter earnings, raised its full-year profit outlook and announced a $20 billion buyback. Adjusted earnings of $3.70 a share topped estimates on revenue of about $50 billion, and GM lifted the midpoint of its full-year adjusted-EPS guidance to about $13.25 (from $13.00) and raised its free-cash-flow outlook. The stock fell anyway on what the guidance implied, not the quarter. The full-year outlook implies a softer fourth quarter — only about $2.7 billion of operating profit versus $4.1 billion in the third, as a Silverado/Sierra redesign temporarily cuts truck deliveries by roughly 35,000 units — the raised $13.25 EPS midpoint still landed just below the roughly $13.41 the Street expected, and management flagged about $2 billion of 2026 cost inflation plus a conditional scenario of more in 2027. Two things that look like culprits mostly were not: the 62% drop in EV sales was already known and reflects a distorted 2025 comparison, and tariff costs are now expected near the low end of an existing range. Crucially, GM did not cut its 2027 outlook — it still expects next year to improve if conditions hold. The move was clearly company-specific — Ford fell only about 1%, Stellantis was flat and the S&P 500 rose — so this was a repricing of GM's forward earnings, not an auto-sector sell-off. The valuation captures the tension: GM trades at barely five to six times the forward earnings it guides to, extraordinarily cheap, because the market prices automakers for the downturn, not the peak. A $20 billion buyback into that multiple is powerfully accretive if earnings hold — but whether they hold in 2027 is exactly the question. Analysts keep a Buy consensus and an average target near $104.

An abstract visualization of a rising stock chart over a molecular antibody and DNA-helix motif in cool teal and violet tones, representing Summit Therapeutics' jump on a new ivonescimab kidney-cancer trial.
Stock AnalysisOctober 19, 2026 · 10 min read

Summit Therapeutics (SMMT) Jumps ~6% on a New Ivonescimab Kidney-Cancer Trial

Summit Therapeutics rose about 6% to roughly $15.57 on October 19 after announcing it had opened a global Phase II trial of ivonescimab — its closely watched lead drug — in previously untreated advanced clear cell kidney cancer, with partner Akeso. The key nuance: this is the opening of a mid-stage study, not a data readout, so it is an incremental catalyst that expands the story rather than one that proves it. Summit is effectively a one-drug company: ivonescimab is a PD-1/VEGF bispecific antibody, licensed from China's Akeso, that outperformed Merck's Keytruda in a Chinese lung-cancer trial — nearly doubling progression-free survival and, in updated data, delivering a significant overall-survival benefit (30.8 vs 22.6 months) — though the global trial behind its U.S. filing has yet to formally confirm that survival benefit in Western patients. With no product revenue and a market value above $12 billion, essentially all of Summit's worth is the market's bet on that drug, so a new indication is a fresh call option on the thesis. Two bigger items frame it: AstraZeneca agreed in late September to invest about $2 billion in Summit equity (a ~12% stake), transforming the balance sheet and removing the financing overhang, and the FDA has a November 14, 2026 decision date on ivonescimab in EGFR-mutated lung cancer — a near-term, binary catalyst that matters far more than a trial start. Monday's move was partly company-specific and partly a tailwind: biotech broadly rallied, with the sector ETF up about 2.5%, but Summit outperformed. The risks are a binary valuation on one molecule, an unconfirmed Western survival benefit, and a stock down roughly 47% from its high. Analysts carry a Buy consensus and an average target near $30, inside a wide range from about $12 to the mid-$40s.